ESR1 and neoplasm: While reduced ER and Ki-67 levels in tumor specimens were noted after treatment with GDC-0810 for one cycle (28 days of treatment) (Fig. 1b), no conclusions could be drawn because baseline and post-dose samples were only available from 3 patients.